concept

SYNUCLEIN

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about SYNUCLEIN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

518Connections

27Hypotheses

0Analyses

46Outgoing

50Incoming

2Experiments

0Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	SYNUCLEIN
Key Genes/Proteins	ABCD3, ACTB, AIF1, AKT, Alpha-Synuclein, ALZHEIMER
Related Diseases	acetylcholine, aging, alpha-synucleinopathies, ALS, Alzheimer Disease

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

AbSci (Zero-Shot Antibody Design)

ai_tool · 455 words

→

Pathway Diagram

graph TD
    SYNUCLEIN["SYNUCLEIN"]
    PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"causes"| SYNUCLEIN
    AUTOPHAGY["AUTOPHAGY"] -->|"activates"| SYNUCLEIN
    P62["P62"] -->|"activates"| SYNUCLEIN
    SQSTM1["SQSTM1"] -->|"activates"| SYNUCLEIN
    MICROGLIA["MICROGLIA"] -->|"inhibits"| SYNUCLEIN
    ASTROCYTES["ASTROCYTES"] -->|"activates"| SYNUCLEIN
    ALS["ALS"] -->|"activates"| SYNUCLEIN
    AMPK["AMPK"] -->|"activates"| SYNUCLEIN

Outgoing (46)

Target	Relation	Type	Str
SELECTIVE AUTOPHAGY	decreases_risk	concept	0.50
DOPAMINERGIC NEURONS	interacts_with	concept	0.50
RAPAMYCIN	interacts_with	concept	0.50
CENTRAL NERVOUS SYSTEM	interacts_with	concept	0.50
DOPAMINERGIC NEURONS	regulates	concept	0.50
DOPAMINERGIC NEURONS	causes	concept	0.50
Proteins	expressed_in	protein	0.50
NEUROFIBRILLARY TANGLES	expressed_in	concept	0.50
LEWY BODY	activates	concept	0.50
Proteins	interacts_with	protein	0.50
AMYLOID-β	interacts_with	concept	0.50
α-SYNUCLEIN	interacts_with	concept	0.50
α-SYNUCLEIN	expressed_in	concept	0.50
Reactive Oxygen Species	causes	process	0.50
RAPAMYCIN	activates	concept	0.50
HCRT	regulates	concept	0.50
DOPAMINERGIC NEURONS	inhibits	concept	0.50
LEWY BODY	expressed_in	concept	0.50
AMYLOID-β	associated_with	concept	0.50
α-SYNUCLEIN	decreases_risk	concept	0.50
Reactive Oxygen Species	activates	process	0.50
NUCLEUS	activates	concept	0.50
ENDOPLASMIC RETICULUM	activates	concept	0.50
α-SYNUCLEIN	inhibits	concept	0.50
α-SYNUCLEIN	associated_with	concept	0.50
DOPAMINE	associated_with	concept	0.50
DOPAMINE	causes	concept	0.50
α-SYNUCLEIN	causes	concept	0.50
DOPAMINE	activates	concept	0.50
α-SYNUCLEIN	activates	concept	0.50
DOPAMINE	inhibits	concept	0.50
DOPAMINE	regulates	concept	0.50
α-SYNUCLEIN	regulates	concept	0.50
Proteins	associated_with	protein	0.50
LEWY BODY	associated_with	concept	0.50
Proteins	activates	protein	0.50
Proteins	inhibits	protein	0.50
LEWY BODY	inhibits	concept	0.50
Gut Microbiota	associated_with	process	0.50
DOPAMINERGIC NEURONS	associated_with	concept	0.50
PI3K/AKT/mTOR	activates	pathway	0.50
LEWY BODY	interacts_with	concept	0.50
Proteins	regulates	protein	0.50
NEUROFIBRILLARY TANGLES	associated_with	concept	0.50
GLIOSIS	inhibits	concept	0.50
MICROGLIAL ACTIVATION	activates	concept	0.50

Incoming (472)

Source	Relation	Type	Str
TAU	associated_with	protein	1.00
MICROGLIA	associated_with	cell_type	1.00
AMYLOID	associated_with	protein	1.00
PARKINSON'S DISEASE	associated_with	disease	1.00
ALZHEIMER'S DISEASE	associated_with	disease	1.00
ASTROCYTES	associated_with	cell_type	1.00
PARKINSON'S DISEASE	causes	disease	0.98
UBIQUITIN	associated_with	protein	0.98
P62	associated_with	protein	0.98
IL-6	associated_with	gene	0.90
PARKINSON'S DISEASE	activates	disease	0.90
SOD1	associated_with	gene	0.82
PARKIN	associated_with	gene	0.82
ALS	associated_with	disease	0.82
NF-KB	associated_with	protein	0.82
TARDBP	associated_with	gene	0.82
PINK1	associated_with	gene	0.82
LRRK2	associated_with	gene	0.82
PARKINSON'S DISEASE	regulates	disease	0.74
TNF	associated_with	gene	0.74
MTOR	associated_with	gene	0.74
TAU	interacts_with	protein	0.74
AMYLOID	interacts_with	protein	0.74
PI3K	associated_with	gene	0.66
AKT	associated_with	gene	0.66
APOE	associated_with	gene	0.66
NRF2	associated_with	gene	0.66
SQSTM1	associated_with	gene	0.66
PARKIN	causes	gene	0.66
MICROGLIA	activates	cell_type	0.64
PARKINSON'S DISEASE	interacts_with	disease	0.56
CASP3	associated_with	gene	0.56
TAU	phosphorylates	protein	0.56
TAU	activates	protein	0.56
LRRK2	activates	gene	0.56
AMYLOID	activates	protein	0.56
MTOR	activates	gene	0.56
MICROGLIA	inhibits	cell_type	0.56
SQSTM1	activates	gene	0.56
ASTROCYTES	activates	cell_type	0.56
P62	activates	protein	0.56
PARKINSON'S DISEASE	mediates	disease	0.56
NDUFA9	interacts_with	gene	0.50
SNCA	interacts_with	gene	0.50
TUBB3	interacts_with	gene	0.50
FRONTOTEMPORAL	activates	concept	0.50
COPD	activates	disease	0.50
disease	expressed_in	disease	0.50
TUBB4B	interacts_with	gene	0.50
CATALASE	activates	protein	0.50

Targeting Hypotheses (27)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S	0.822	neurodegeneration	What are the mechanisms by which gut mic
Bacterial Curli Amyloid → Nucleation of α-Synuclein Misfoldi	0.720	neurodegeneration	What are the mechanisms by which gut mic
Ferroptosis Inhibition for α-Synuclein Neuroprotection	0.705	neurodegeneration	Gene expression changes in aging mouse b
A downstream LRRK2-Rab10-JIP4 lysosomal stress loop promotes	0.680	neurodegeneration	Do pathogenic LRRK2 mutations amplify vo
Physiological SCFAs may confer indirect anti-synuclein benef	0.670	neurodegeneration	Do physiological concentrations of SCFAs

Physiological SCFAs may reduce alpha-synuclein burden primar	0.650	neurodegeneration	Do physiological concentrations of SCFAs
Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro	0.642	neurodegeneration	What are the mechanisms by which gut mic
Autophagosome-Lysosome Fusion Defects as Primary Driver of α	0.630	neurodegeneration	Gap 006 analysis (archived stub)
LRRK2 Kinase Inhibition Reduces α-Synuclein Spread via Lysos	0.620	neurodegeneration	Test Hypothesis Fixtures
H7: Enteric Nervous System Alpha-Synuclein Propagation Block	0.620	neurodegeneration	How does engineered C. butyricum cross t
CSF ApoE- and clusterin-rich lipoprotein particles stabilize	0.606	neurodegeneration	Which specific CSF molecular components
c-Abl Tyrosine Kinase Activation Drives α-Synuclein Phosphor	0.605	neurodegeneration	Legacy Pre-Pipeline Hypothesis Import
Exosomal α-Synuclein as an Interneuronal Propagation Vector	0.595	neurodegeneration	Legacy Pre-Pipeline Hypothesis Import
Ganglioside-rich extracellular vesicles preserve alpha-synuc	0.582	neurodegeneration	Which specific CSF molecular components
Selective c-Abl Inhibition Promotes α-Synuclein Clearance vi	0.580	neurodegeneration	Test Hypothesis Fixtures
Neuronal Subtype-Specific Alpha-Synuclein Expression Normali	0.571	neurodegeneration	De Novo Binder Design Targeting Alpha-Sy
Direct neuronal HDAC inhibition is unlikely to mediate thera	0.560	neurodegeneration	Do physiological concentrations of SCFAs
AMPK Activation to Restore Autophagy and Clear α-Synuclein A	0.559	neurodegeneration	Does RGS6 upregulation or D2 autorecepto
Physiological SCFAs may worsen alpha-synuclein pathology thr	0.550	neurodegeneration	Do physiological concentrations of SCFAs
Cross-Seeding: Gut Microbiome-Derived Bacterial Curli and Fu	0.540	neurodegeneration	How does gut microbiome dysbiosis contri
Gut Barrier Permeability-α-Synuclein Axis Modulation	0.533	neurodegeneration	What are the mechanisms by which gut mic
Microbial Metabolite-Mediated α-Synuclein Disaggregation	0.511	neurodegeneration	What are the mechanisms by which gut mic
Sulfated glycans and metal-binding CSF proteins brace alpha-	0.489	neurodegeneration	Which specific CSF molecular components
Propionate may outperform acetate or butyrate at physiologic	0.440	neurodegeneration	Do physiological concentrations of SCFAs
GSK3β Inhibition to Prevent α-Synuclein Phosphorylation and	0.429	neurodegeneration	Does RGS6 upregulation or D2 autorecepto
Glucosylceramide accumulation nucleates alpha-synuclein aggr	0.000	Parkinson's disease	GBA-Synuclein Loop Therapeutics for PD
H2S/butyrate imbalance drives enteric alpha-synuclein pathol	0.000	Parkinson's disease	Gut Microbiome Analysis in Parkinson's D

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (2)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
S-equol-induced ferroptosis mechanism in TNBC cells	exploratory	Triple negative breast cancer	0.900	0.00	TNBC cell lines	proposed	N/A
Gandouling protection against brain injury in Wilson's disease via SIR	validation	Hepatolenticular degeneration	0.900	0.00	TX mice (Wilson's disease mode	proposed	N/A

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year
GPX4 promotes optic nerve regeneration and retinal ganglion cell neuroprotection [PMID:41485051]	Yang M, Bian F, Feng X, Li L, Huang H et	Mol Ther	2026
Extracellular GPX4 impairs antitumor immunity via dendritic ZP3 receptors. [PMID:41494530]	Liu J, Cai X, Lin J, Zhang Z, Zhou Q et	Cell	2026
Aging at the Crossroads of Cuproptosis and Ferroptosis: From Molecular Pathways [PMID:41516398]	Gromadzka G, Tarnacka B, Cieślik M	Int J Mol Sci	2026
Ferroptosis in neurological diseases: moving towards therapeutic intervention. [PMID:41554903]	Tuo QZ, Bush AI, Lei P	Mol Psychiatry	2026
Fin(e)-tuning ferroptosis. [PMID:41576911]	Szylo KJ, Dixon SJ	Mol Cell	2026
GPX4-dependent ferroptosis governs ILC2 homeostasis and colitis progression. [PMID:41663525]	Liu G, Wang Y, Huang H, Wang J, Yang J e	Cell Mol Immunol	2026
A GPX1-OSBPL8 axis mediates noncanonical in vivo ferroptosis and cancer growth s [PMID:41720096]	Xia Z, Yang X, Samovich SN, Tyurina YY,	Cell	2026
The crossroads of inflammation and oxidative stress: A review of the interplay b [PMID:41722697]	Park WH	Pharmacol Res	2026
Ferroptosis in Cerebral Ischemia/Reperfusion Injury: Mechanistic Drivers and The [PMID:41738060]	Song C, Liu Z, Tang J, Huang Y	Neuropsychiatr Dis Treat	2026
Decoding GPX4 regulation in ferroptosis: mechanisms and therapeutic implications [PMID:41826143]	Chen X	Trends Mol Med	2026
Computational examination of magainin-I-KL mediated disruption of E. coli biofil [PMID:41724836]	Vinutha AS, Akshay S, Sree Agash SG, Cha	Archives of microbiology	2026
Montelukast Modulates MPTP-induced Ferroptosis and Neuroinflammation Linked To t [PMID:41712018]	["Jung Yu Jin", "Choi Hyunsu", "Lee Seon	Neuromolecular medicine	2026
The cytoplasmic protein YedX is a potent inhibitor of CsgA amyloid assembly in E [PMID:41581877]	Gurnani B, Jain N	The Journal of biological chem	2026
A fin-loop-like structure in GPX4 underlies neuroprotection from ferroptosis. [PMID:41349546]	Lorenz SM, Wahida A, Bostock MJ, Seibt T	Cell	2026
Hypoxia-inducible factor-1 as targets for neuroprotection : from ferroptosis to [PMID:39466326]	["Changyong Wang", "Shanyu Lv", "Hongyan	Neurological sciences : offici	2025
Gentiopicroside Attenuated Dopaminergic Neurodegeneration via Inhibiting Neuroin [PMID:40256942]	Unknown	Basic & clinical pharmacol	2025
Astragenol alleviates neuroinflammation and improves Parkinson's symptoms throug [PMID:40306495]	["Shengnan Xiao", "Lianmei Liu", "Xuemei	Journal of ethnopharmacology	2025
Schisanhenol Inhibits MPTP/MPP<sup>+</sup>-Induced Ferroptosis in Dopaminergic N [PMID:41460594]	Unknown	Neurochemical research	2025
Carvedilol Confers Neuroprotective Activity Through Modulating Ferroptosis Key P [PMID:41243756]	Unknown	Journal of biochemical and mol	2025
Betulinic acid protects SH-SY5Y cells exposed to lipopolysaccharide and ferrous [PMID:40985323]	Pandey SK, Singh H, Ahmad S, Singh RK	Free radical research	2025

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning SYNUCLEIN in their description or question text

Physiological SCFAs may reduce alpha-synuclein burden primarily through a gut-fi

Score: 0.650 · neurodegeneration · 2026-04-24

Low-micromolar systemic SCFA exposure is unlikely to directly drive substantia nigra alpha-synuclein clearance, but colo

Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cross-Seeding

Score: 0.642 · neurodegeneration · 2026-04-02

## Mechanistic Overview Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cross-Seeding starts from the claim tha

Autophagosome-Lysosome Fusion Defects as Primary Driver of α-Synuclein Propagati

Score: 0.630 · neurodegeneration · 2026-04-22

## **Molecular Mechanism and Rationale** The autophagosome-lysosome fusion process represents a critical checkpoint in

LRRK2 Kinase Inhibition Reduces α-Synuclein Spread via Lysosomal Enhancement

Score: 0.620 · neurodegeneration · 2026-04-26

LRRK2 G2019S gain-of-function mutation hyperactivates kinase activity, dysregulating RAB GTPases and impairing lysosomal

H7: Enteric Nervous System Alpha-Synuclein Propagation Blocker via Gut Barrier R

Score: 0.620 · neurodegeneration · 2026-04-15

## Mechanistic Overview H7: Enteric Nervous System Alpha-Synuclein Propagation Blocker via Gut Barrier Restoration start

CSF ApoE- and clusterin-rich lipoprotein particles stabilize disease-relevant al

Score: 0.606 · neurodegeneration · 2026-04-25

Specific lipoprotein particles bind fibril surfaces and preserve polymorph architecture and seeding fidelity outside the

c-Abl Tyrosine Kinase Activation Drives α-Synuclein Phosphorylation and Neurodeg

Score: 0.605 · neurodegeneration · 2026-04-26

c-Abl (ABL1) phosphorylates α-synuclein at Y39, promoting aggregation and neuronal toxicity. Nilotinib (FDA-approved for

Exosomal α-Synuclein as an Interneuronal Propagation Vector in Parkinson's Disea

Score: 0.595 · neurodegeneration · 2026-04-26

Misfolded α-synuclein aggregates are transmitted via exosomes from donor to recipient neurons, templating endogenous aSy

Ganglioside-rich extracellular vesicles preserve alpha-synuclein fibril conforma

Score: 0.582 · neurodegeneration · 2026-04-25

Membrane-derived cofactors in extracellular vesicles maintain polymorph fidelity and templating competence.

Selective c-Abl Inhibition Promotes α-Synuclein Clearance via Autophagy

Score: 0.580 · neurodegeneration · 2026-04-26

c-Abl kinase is activated in PD substantia nigra and phosphorylates parkin at Tyr143, inhibiting its E3 ligase activity

Neuronal Subtype-Specific Alpha-Synuclein Expression Normalization

Score: 0.571 · neurodegeneration · 2026-04-04

## Mechanistic Overview Neuronal Subtype-Specific Alpha-Synuclein Expression Normalization starts from the claim that mo

Direct neuronal HDAC inhibition is unlikely to mediate therapeutic alpha-synucle

Score: 0.560 · neurodegeneration · 2026-04-24

The classic butyrate neuroprotection narrative likely depends on pharmacologic exposure sufficient for HDAC inhibition,

AMPK Activation to Restore Autophagy and Clear α-Synuclein Aggregates

Score: 0.559 · neurodegeneration · 2026-04-18

## Mechanistic Overview AMPK Activation to Restore Autophagy and Clear α-Synuclein Aggregates starts from the claim that

Physiological SCFAs may worsen alpha-synuclein pathology through FFAR2/GPR43-NLR

Score: 0.550 · neurodegeneration · 2026-04-24

A key liability hypothesis is that low-range SCFA signaling can be receptor-biased toward inflammasome activation in sus

Cross-Seeding: Gut Microbiome-Derived Bacterial Curli and Fungal Amyloid Synergi

Score: 0.540 · neurodegeneration · 2026-04-26

Commensal bacteria (E. coli, Salmonella) produce curli amyloid fibers encoded by the csg operon, while Candida and Sacch